Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Generex Biotechnology Corp. (GNBT) and Elias Shaker & Company Sign Sales Agreement

Generex Biotechnology Corp., engaged in the research, development and commercialization of drug delivery systems and technologies, announced earlier today that it has entered into a sales agreement with Elias Shaker & Company, a leading national full-service consumer product brokerage firm, to represent its novel consumer products to national and regional retail and wholesale accounts in the USA.

Founded approximately 85 years ago by Elias Shaker, the company has established itself as a respected, quality-conscious, service-driven organization. The firm has established relationships with all class of trades from national drug chains and wholesalers to mass merchandisers/club stores, grocery chains, food wholesalers, convenience stores and distributors and specialty stores, representing 200,000 plus retail points of purchase throughout the USA.

“We are very excited to partner with an experienced and results-driven sales firm such as Elias Shaker to represent our proprietary consumer products in the USA,” stated Rose Perri, the Company’s Chief Operating Officer. ”We welcome the opportunity to have our products showcased and represented by a company with an extensive history in retail.”

“After reviewing Generex’s consumer products, its current distribution and discussing it with our sales team internally we are very confident in taking their product-line to the next level by focusing on building new distribution, supporting established accounts and taking advantage of unique promotional opportunities that may arise which will ultimately grow brand awareness and sales,” commented Bruce Funk, Elias Shaker & Company’s President.

According to the press release, Elias Shaker & Company will market and sell the following Generex consumer products: Glucose RapidSpray™, Crave-NX™ Diet Aid Spray, BaBOOM!™ Energy Spray, and Glucose RapidSpray™ for Pet.

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *